Wave life sciences to host analyst and investor virtual event, “towards the clinic: spotlight on rna editing for aatd,” on september 28, 2022

Focus on wve-006, a first-in-class rna editing development candidate for aatd, and feature aatd expert presentation focus on wve-006, a first-in-class rna editing development candidate for aatd, and feature aatd expert presentation

WVE Ratings Summary

WVE Quant Ranking